Bank of Montreal
PLRX icon

Bank of Montreal’s Pliant Therapeutics PLRX Stock Holding History

Bank of Montreal’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-868
Closed -$32K – 4624
2021
Q1 		$32K Sell
868
-759
-47% -$24.6K ﹤0.01% 3883
2020
Q4 		$45K Buy
1,627
+1,143
+236% +$28.7K ﹤0.01% 4006
2020
Q3 		$11K Buy
+484
New +$12.1K ﹤0.01% 4101

Other funds holding PLRX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Bank of Montreal's PLRX Position: Q2 2021 in Review

Bank of Montreal sold out of Pliant Therapeutics (PLRX) in Q2 2021, closing a stake of 868 shares — an estimated $32K sold.

Bank of Montreal first reported a position in PLRX in Q3 2020 and held it in 3 quarters. The position peaked at $45K in Q4 2020. 81 funds tracked by Wall St. Rank hold PLRX as of Q2 2021.

  • Bank of Montreal reported no remaining Pliant Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 868 Pliant Therapeutics shares in Q2 2021, an estimated $32K.
  • Bank of Montreal first reported a position in Pliant Therapeutics in Q3 2020 and held it in 3 quarters.
  • Bank of Montreal's Pliant Therapeutics position peaked at $45K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.